7-methyl-6,8-bis(methylthio)pyrrolo(1,2-a)pyrazine

Names

[ Name ]:
7-methyl-6,8-bis(methylthio)pyrrolo(1,2-a)pyrazine

[Synonym ]:
7-methyl-6,8-dimethylthio-pyrrolo<1,2-a>pyrazine
MIII
Mbmtpp
6,8-dimethylthio-7-methylpyrrolo <1,2-a> pyrazine
Metabolite III

Chemical & Physical Properties

[ Density]:
1.25g/cm3

[ Molecular Formula ]:
C₁₀H₁₂N₂S₂

[ Molecular Weight ]:
224.34600

[ Exact Mass ]:
224.04400

[ PSA ]:
67.90000

[ LogP ]:
3.08650

[ Index of Refraction ]:
1.656

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ RIDADR ]:
NONH for all modes of transport

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Articles

Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1.

Clin. Pharmacol. Ther. 88(3) , 360-8, (2010)

Oltipraz is a potential candidate drug for the treatment of liver fibrosis (LF) and liver cirrhosis (LC). The pharmacokinetics of oltipraz and its major rearranged metabolite (7-methyl-6,8-bis(methylt...

Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.

Mol. Pharmacol. 48(1) , 15-20, (1995)

Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication in vitro (ED50 approximately 10 microM), undergoes extensive metabolism in vivo. Most of the orally administered drug undergoe...